1. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
- Author
-
Bruzone, Santiago Oscar, Coronel, Maria Jimena, Gruz, Fernando M., MacKinnon, Ignacio, George, Jacob, Muller, Kate, Lee, Samuel S., Caussy, Cyrielle, Petit, Jean Michel, Ari, Ziv Ben, Braun, Marius, Katchman, Helena, Lurie, Yoav, Veitsman, Ella, Zuckerman, Eli, Aghemo, Alessio, Basili, Stenfania, Fracanzani, Anna Ludovica, Pietrangelo, Antonello, Sacerdoti, David, Rubio Arce, Jose Francisco, de Guevara Cetina, Alma Laura Ladron, Chavez-Tapia, Norberto Carlos, Reyes, Eira Cerda, Pinzon Te, Lourdes Lol-Be, Baker, John R., Ngu, Jeffrey, Orr, David, Janczewska, Ewa, Matusik, Pawel, Stanislaw Sadurski, Maciej Murawski, Akinina, Anna Valerievna, Alpenidze, Diana Nodarievna, Bogomolov, Pavel, Ermakova, Polina Yurievna, Golovach, Albina V., Kim, Sang Gyune, Lee, Jin-Woo, Paik, Yong Han, Park, Jun Yong, Yeon, Jong Eun, Blasco, Victor Vargas, Madueno, Francisco Jose Tinahones, Panero, Jose Luis Calleja, Perez, Esther Molina, Romero-Gómez, Manuel, Cheng, Pin-Nan, Jeng, Wen-Juei, Liu, Chun-Jen, Akyuz, Filiz, Balaban, Hatice Yasemin, Basaranoglu, Metin, Demir, Tevfik, Idilman, Ramazan, Karakan, Tarkan, Gyrina, Olga, Kolesnikova, Olena Vadimivna, Pyvovar, Sergiy M., Oliinyk, Oleksandr, Skrypnyk, Igor, Bassan, Isaac, Bowman, William Kelly, Denham, Douglas Scott, Ghalib, Reem, Lawitz, Eric J., Lucas, Kathryn Jean, Mohseni, Rizwana H., Sanchez, William Eduardo, Vierling, John Moore, Lawitz, Eric, Shankar, R. Ravi, Chaudhri, Eirum, Liu, Jie, Lam, Raymond L.H., Kaufman, Keith D., and Engel, Samuel S.
- Published
- 2023
- Full Text
- View/download PDF